LLY Sep 2023 330.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:46PM EST. Market open.
| Previous close | 44.40 |
| Open | 45.78 |
| Bid | 39.45 |
| Ask | 42.90 |
| Strike | 330.00 |
| Expiry date | 2023-09-15 |
| Day's range | 44.40 - 45.78 |
| Contract range | N/A |
| Volume | |
| Open interest | 109 |
- Zacks
Drug/Biotech Stocks Q4 Earnings Due on Feb 2: GILD, MRK & Others
Let's look at the four biotech/pharma companies slated to release quarterly results on Feb 2.
- Motley Fool
Why the FDA's Rejection of Eli Lilly's Alzheimer's Drug Is Actually Great News for the Stock
When the Food and Drug Administration (FDA) rejects a key drug from a healthcare company, it can send the stock spiraling into a sell-off. In order for the FDA to be confident in a drug's effectiveness, it needs to have a large enough sample size to evaluate it. Unfortunately, in Eli Lilly's case, it simply didn't have enough data points for the agency to make a positive conclusion about the treatment and grant it accelerated approval.
- Simply Wall St.
Eli Lilly (NYSE:LLY) shareholders have earned a 37% CAGR over the last five years
We think all investors should try to buy and hold high quality multi-year winners. And highest quality companies can...
© 2023 Yahoo. All rights reserved.
